| SAO PAULO, April 24
SAO PAULO, April 24 Johnson & Johnson,
Novartis AG and Takeda Pharmaceutical Co Ltd
are in talks with the controlling bloc of Brazilian drugmaker
Hypermarcas SA for a buyout, two people with
knowledge of the matter said on Monday.
Families owning investment vehicles Igarapava Participações
SA and Maiorem SA de CV, which hold a combined 34 percent of
Hypermarcas, hired the investment banking units of Banco
Bradesco SA and Credit Suisse Group AG to
advise on a sale, said the sources, who requested anonymity
because the talks are private.
(Reporting by Tatiana Bautzer; Additional reporting by Bruno
Federowski; Editing by Chizu Nomiyama)